RBP4 and Insulin resistance: Finally, we wanted to validate that the observed changes in serum RBP-4 levels following chiglitazar 32 mg, chiglitazar 48 mg, and sitagliptin 100 mg treatment could contribute to the improved insulin resistance observed in these patients.